DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime.

Source:http://linkedlifedata.com/resource/pubmed/id/15650426

Download in:

View as

General Info

PMID
15650426